Ezose Sciences has entered into a biotech partnering deal with Kyowa Hakko Kirin, a big pharma company, to collaborate on glycomics studies using Ezose’s proprietary GlycanMap technology platform
Kyowa Hakko Kirin will fund several glycan-biomarker and other discovery projects, with an option for further research and development in the light of this biotech partnering deal.
Other details of the biotech partnering agreement were not disclosed.
For further deal information visit Current Agreements (subscription required)
Read: more on Kyowa Hakko Kirin deals in pharma, biotech, life science partnering deal news, insights and glossary
Related reports: Partnering Deals and Alliances with Kyowa Hakko Kirin
View: Current Partnering’s Partnering Scorecard – view top life science partnering deals by value
View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making
View: Current Partnering’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity